[go: up one dir, main page]

TR200000416T2 - Neisseria loctoferrin bağlayıcı protein. - Google Patents

Neisseria loctoferrin bağlayıcı protein.

Info

Publication number
TR200000416T2
TR200000416T2 TR2000/00416T TR200000416T TR200000416T2 TR 200000416 T2 TR200000416 T2 TR 200000416T2 TR 2000/00416 T TR2000/00416 T TR 2000/00416T TR 200000416 T TR200000416 T TR 200000416T TR 200000416 T2 TR200000416 T2 TR 200000416T2
Authority
TR
Turkey
Prior art keywords
neisseria
loctoferrin
binding protein
polypeptides
polynucleotides
Prior art date
Application number
TR2000/00416T
Other languages
English (en)
Inventor
Margareta Pettersson-Fernholm Annika
Petrus Maria Tommassen Johannes
Original Assignee
University Of Utrecht
Technology Foundation (Technologiestichting Stw)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9717423.9A external-priority patent/GB9717423D0/en
Priority claimed from GBGB9802544.8A external-priority patent/GB9802544D0/en
Application filed by University Of Utrecht, Technology Foundation (Technologiestichting Stw) filed Critical University Of Utrecht
Publication of TR200000416T2 publication Critical patent/TR200000416T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

LbpB polipeptitleri ve polinükleotitleri ve bu tip polipeptitleri rekombinan teknikler yolu ile meydana getirmek için yöntemler açiklanmaktadir. Ayni zamanda digerleri arasinda Neisseria'nin etkeni oldugu hastaliklarin tedavisi için ve bu tip durumlarin diagnostik tayinleri için, protokollerin tasariminda LbpB polipeptitleri ve polinükleotitlerinin kullanilmasi için yöntemler de açiklanir.
TR2000/00416T 1997-08-15 1998-08-10 Neisseria loctoferrin bağlayıcı protein. TR200000416T2 (tr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9717423.9A GB9717423D0 (en) 1997-08-15 1997-08-15 Vaccine
GBGB9802544.8A GB9802544D0 (en) 1998-02-05 1998-02-05 Vaccine

Publications (1)

Publication Number Publication Date
TR200000416T2 true TR200000416T2 (tr) 2000-07-21

Family

ID=26312080

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/00416T TR200000416T2 (tr) 1997-08-15 1998-08-10 Neisseria loctoferrin bağlayıcı protein.

Country Status (18)

Country Link
US (1) US7105316B2 (tr)
EP (1) EP1003874B1 (tr)
JP (1) JP2001514894A (tr)
KR (1) KR100509712B1 (tr)
CN (1) CN1204253C (tr)
AT (1) ATE344325T1 (tr)
AU (1) AU744733B2 (tr)
BR (1) BR9811907A (tr)
CA (1) CA2301332A1 (tr)
CO (1) CO4810233A1 (tr)
DE (1) DE69836333T2 (tr)
ES (1) ES2275314T3 (tr)
IL (1) IL134436A0 (tr)
NO (1) NO20000731L (tr)
NZ (1) NZ502750A (tr)
PL (1) PL194800B1 (tr)
TR (1) TR200000416T2 (tr)
WO (1) WO1999009176A1 (tr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1860191A3 (en) * 1999-05-19 2008-02-13 Novartis Vaccines and Diagnostics S.r.l. Combination neisserial compositions
GB0007433D0 (en) * 2000-03-27 2000-05-17 Microbiological Res Authority Recombinant transferrin binding proteins
GB0011108D0 (en) * 2000-05-08 2000-06-28 Microscience Ltd Virulence gene and protein and their use
GB0107219D0 (en) * 2001-03-22 2001-05-16 Microbiological Res Authority Immunogenic commensal neisseria sequences
CA2493977A1 (en) 2002-08-02 2004-02-19 Glaxosmithkline Biologicals Sa Vaccine composition comprising lipooligosaccharide with reduced phase variability
AU2004277342B2 (en) 2003-10-02 2010-12-16 Glaxosmithkline Biologicals S.A. Pertussis antigens and use thereof in vaccination
GB0409748D0 (en) * 2004-04-30 2004-06-09 Chiron Srl Lactoferrin cleavage
EP2032161B1 (en) 2006-06-12 2012-07-11 GlaxoSmithKline Biologicals S.A. L3v los vaccines
JP2013521770A (ja) 2010-03-10 2013-06-13 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム ワクチン組成物
JP2023115806A (ja) * 2022-02-08 2023-08-21 国立大学法人京都工芸繊維大学 ラクトフェリン、コンカナバリンａ、リゾチーム及び／またはヘモグロビンを介して抗体等が固定されたニトロセルロース膜の製造方法及び抗原結合性等の増強方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2692592B1 (fr) * 1992-06-19 1995-03-31 Pasteur Merieux Serums Vacc Fragments d'ADN codant pour les sous-unités du récepteur de la transferrine de Neisseria meningitidis et procédés les exprimant.
FR2720408B1 (fr) * 1994-05-31 1996-08-14 Pasteur Merieux Serums Vacc Fragments Tbp2 de Neisseria meningitidis.
US6048539A (en) * 1995-11-02 2000-04-11 Connaught Laboratories Limited Lactoferrin receptor protein

Also Published As

Publication number Publication date
US7105316B2 (en) 2006-09-12
IL134436A0 (en) 2001-04-30
NO20000731D0 (no) 2000-02-14
EP1003874B1 (en) 2006-11-02
KR100509712B1 (ko) 2005-08-24
CN1275164A (zh) 2000-11-29
AU9261398A (en) 1999-03-08
US20040131634A1 (en) 2004-07-08
EP1003874A1 (en) 2000-05-31
JP2001514894A (ja) 2001-09-18
NZ502750A (en) 2002-03-01
PL194800B1 (pl) 2007-07-31
ATE344325T1 (de) 2006-11-15
KR20010022952A (ko) 2001-03-26
ES2275314T3 (es) 2007-06-01
WO1999009176A1 (en) 1999-02-25
NO20000731L (no) 2000-03-31
AU744733B2 (en) 2002-02-28
BR9811907A (pt) 2000-08-15
CN1204253C (zh) 2005-06-01
PL338649A1 (en) 2000-11-06
CO4810233A1 (es) 1999-06-30
DE69836333T2 (de) 2007-04-19
DE69836333D1 (de) 2006-12-14
CA2301332A1 (en) 1999-02-25

Similar Documents

Publication Publication Date Title
MXPA02011656A (es) Moleculas de acido nucleico nrg-2, polipeptidos, y metodos de diagnostico y terapeuticos.
TR200003181T2 (tr) Gelişmiş çoğaltılabilirliğe sahip FAP alfa'ya özgü antikor
DK0960127T3 (da) Isoleret dimert fibroblastaktiverende protein-alfa og anvendelser deraf
DK1005540T3 (da) IKK-beta-proteiner, nukleinsyrer og fremgangsmåder
ATE180261T1 (de) Durch menschliche lymphozyten produzierte proteine, die für diese proteine kodierende dns und pharmazeutische und biologische verwendungen
IL127558A0 (en) Hepatocyte growth factor receptor agonists and uses thereof
BG101103A (bg) Теломераза при бозайници
ATE444967T1 (de) Spezifische bindungsmittel von human angiopoietin-2
DE69936312D1 (de) Mutanten von op-1
HUT77049A (hu) Katepszin-02-fehérjék, -nukleinsavak és -ellenanyagok
ATE173014T1 (de) Afamin: ein menschliches serum albumin ähnliches protein
NO971341D0 (no) Promoter for reseptor tyrosinkinase TIE
TR200000416T2 (tr) Neisseria loctoferrin bağlayıcı protein.
TR200003347T2 (tr) Neisseria meningitidis'denBASB029 polinükleotidleri ve polipeptidler
EE05497B1 (et) Polüpeptiid, lahustuv CRAM-1 polüpeptiid, polünukleotiid ja antikeha
FR2806739B1 (fr) Genes impliques dans les maladies inflammatoires de l'intestin et leur utilisation
DE69634489D1 (de) Adenovirus dodekahedrischer proteinkomplex, dieser enthaltende zusammensetzung und verwendungen davon
DE69714451D1 (de) Prionbindende proteine und deren verwendungen
PT723552E (pt) Oligopeptidos derivados de fragmentos de proteina reactiva c
EP0885959A3 (en) Human Wnt-5b protein
TR199700842T1 (tr) Insan DNase I Varyantlari.
ATE528392T1 (de) Neues protein und dessen dns
DE60042056D1 (de) Menschliche Carnosinase 2
DE69733026D1 (de) Cyclin e spezifische konstrukte und komplexe
WO1999046381A3 (en) Human fgf gene and gene expression products